Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.
EClinicalMedicine
View this publicationEClinicalMedicine
View this publicationPathogens (Basel, Switzerland)
View this publicationCells
View this publicationNature communications
View this publicationPharmaceutics
View this publicationEuropean journal of immunology
View this publicationNutrients
View this publicationHamostaseologie
View this publicationRheumatology (Oxford, England)
View this publicationHamostaseologie
View this publication